Table 4. Compound MRM Transitions and Conditions.
| compound | parent ion | product ion | DP (V) | CE (eV) |
|---|---|---|---|---|
| 7-EC | 190.9 | 163.0 | 56 | 23 |
| propranolol | 260.4 | 183.2 | 40 | 25 |
| verapamil | 455.4 | 165.1 | 31 | 35 |
| 15 | 406.1 | 238.3 | 46 | 35 |
| compound | parent ion | product ion | DP (V) | CE (eV) |
|---|---|---|---|---|
| 7-EC | 190.9 | 163.0 | 56 | 23 |
| propranolol | 260.4 | 183.2 | 40 | 25 |
| verapamil | 455.4 | 165.1 | 31 | 35 |
| 15 | 406.1 | 238.3 | 46 | 35 |